Latest Insider Transactions at Vera Therapeutics, Inc. (VERA)
This section provides a real-time view of insider transactions for Vera Therapeutics, Inc. (VERA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vera Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vera Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$65,000
$13.6 P/Share
|
|
May 31
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
400
-1.56%
|
$6,000
$15.22 P/Share
|
|
May 31
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.54%
|
$2,400
$6.37 P/Share
|
|
Feb 10
2022
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
333,333
+8.86%
|
$4,999,995
$15.0 P/Share
|
|
Feb 10
2022
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,333
+8.86%
|
$4,999,995
$15.0 P/Share
|
|
Feb 10
2022
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
266,666
+7.73%
|
$3,999,990
$15.0 P/Share
|
|
Feb 06
2022
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Open market or private purchase
|
Direct |
5,714
+20.12%
|
$39,998
$7.0 P/Share
|
|
Feb 06
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
14,285
+22.24%
|
$99,995
$7.0 P/Share
|
|
May 18
2021
|
Andrew Cheng |
BUY
Conversion of derivative security
|
Indirect |
17,488
+50.0%
|
-
|
|
May 18
2021
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
909,090
+22.7%
|
$9,999,990
$11.0 P/Share
|
|
May 18
2021
|
Patrick G Enright |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Beth C Seidenberg |
BUY
Conversion of derivative security
|
Indirect |
1,343,152
+34.66%
|
-
|
|
May 18
2021
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
727,272
+19.97%
|
$7,999,992
$11.0 P/Share
|
|
May 18
2021
|
Maha Katabi |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
909,090
+22.7%
|
$9,999,990
$11.0 P/Share
|
|
May 18
2021
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
727,272
+19.97%
|
$7,999,992
$11.0 P/Share
|
|
May 18
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Indirect |
772,727
+20.7%
|
$8,499,997
$11.0 P/Share
|
|
May 18
2021
|
Kurt Von Emster Director |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Abingworth LLP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
772,727
+20.7%
|
$8,499,997
$11.0 P/Share
|
|
May 18
2021
|
Abingworth LLP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 17
2021
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Direct |
17,828
+50.0%
|
$213,936
$12.04 P/Share
|